Document:

exv10w1

 

Exhibit 10.1

RTW, INC. AND
SUBSIDIARY

AMENDMENT TO THE EMPLOYMENT AGREEMENT

BETWEEN RTW, INC. AND JEFFREY B. MURPHY

 

 

	 	 	 
	

	 	RTW®, Inc.

P.O. Box 390327

Minneapolis, MN 55439-0327

	

	 	Main: 952-893-0403

800-789-2242

Fax: 952-893-3700

March 9, 2005

Mr. Jeffrey B. Murphy

President and Chief Executive Officer

RTW, Inc.

8500 Normandale Lake Blvd

Suite 1400

Minneapolis, MN 55437

Dear Mr. Murphy:

On March 12, 2004, RTW, Inc. (the “Company”) and you entered into an Employment
Agreement (“Agreement”) setting forth the terms and conditions of your employment by the
Company. That Agreement compensated you at a base salary of $250,000 per year and had a
termination date of March 31, 2005, unless and until terminated in accordance with the terms
of the Agreement.

The Board of Directors of RTW, Inc. desires to extend the term of the Agreement for one year
until March 31, 2006 under the same terms and conditions as the original Agreement, except
that your annual base salary will be $275,000 effective April 1, 2005.

Please acknowledge your acceptance of this extension and your new base salary as indicated
below.

Sincerely,

John O. Goodwyne

Chairman of the Board

RTW, Inc.

ACCEPTANCE:

I acknowledge and accept the extension of the Agreement for one year, expiring on March 31,
2006, and the adjustment of my base salary to $275,000 per year.

	 	 	 	 	 
	 	 	 
	 	                                               /s/ Jeffrey B. Murphy
 	 
	 	Jeffrey B. Murphyexv10w2

 

Exhibit 10.2

RTW, INC. AND SUBSIDIARY

Summary of Non-Employee Director Compensation

On March 8, 2005 and March 9, 2005 the Company’s Board of Directors and its Compensation
Committee increased the compensation payable to its non-employee directors. Retroactive to January
1, 2005, payable in equal quarterly installments, the Company will pay: (i) each non-employee
director an annual fee of $25,000; (ii) the Chairman of the Board an annual fee of $65,000; (iii)
the Chairman of the Audit Committee an annual fee of $45,000; and (iv) non-employee Board members
who require an extra day of travel to attend meetings an annual fee of $35,000. The Company will
pay the Chairman Emeritus an annual fee of $100,000. Other than the Chairman Emeritus, each
non-employee director, who is serving a continuing term or who is re-elected at the Annual Meeting
of Shareholders will be issued a non-qualified option to purchase 2,500 shares of common stock,
expiring in ten years, vesting over three years beginning one year from the date of grant. The
options expire one year after the individual ceases to be a director.exv10w34

 

EXHIBIT 10.34

CONSULTING AGREEMENT FOR INDEPENDENT CONTRACTORS

          This Agreement is made by IntraBiotics Pharmaceuticals, Inc., (“IntraBiotics”) and
Gregory W. Schafer, (“Contractor”), effective this 15 day
of January, 2005 (the “Effective Date”) for the purpose of setting forth the exclusive terms and
conditions by which IntraBiotics will acquire Contractor’s services.

          In consideration of the mutual obligations specified in this Agreement, and any compensation
paid to Contractor for his or her services, the parties agree to the following:

	 	1.  	Engagement of Services.
	 
	 	   	Contractor, pursuant to the terms of this Agreement, is retained by IntraBiotics to provide
the services as described in Exhibit A.
	 
	 	   	IntraBiotics is not obligated to issue any additional orders for work by Contractor under
this Agreement. Contractor shall not commence services under this Agreement until this
Agreement is signed and delivered by an authorized representative of IntraBiotics.
	 
	 	2.  	Payment for Services.
	 
	 	   	IntraBiotics shall pay Contractor, on account of services provided pursuant hereto, a fee of
$15,000 per month, prorated as appropriate, of said services provided. Travel and
out-of-pocket expenses will be billed separately at cost (original receipts required).
Payment shall be made within 15 days upon presentation of invoice by Contractor.
	 
	 	3.  	Nondisclosure And Trade Secrets.
	 
	 	   	During the term of this Agreement and in the course of Contractor’s performance hereunder,
Contractor may receive and otherwise be exposed to confidential and proprietary information
owned by IntraBiotics or received by IntraBiotics from third parties pursuant to an
obligation of confidentiality with respect thereto, relating to IntraBiotics’ business
practices, strategies and technologies. Such confidential and proprietary information may
include, but not be limited to, any compound, extract, media, vector, cell, cell line,
formulation or sample; any procedure, discovery, invention, formula, data, results, idea or
technique; any trade secret, trade dress, copyright, patent or other intellectual property
right or registration or application therefor or materials relating thereto; and any
information relating to the foregoing or to any research, development, manufacturing,
engineering, marketing, servicing, sales, financing, legal or other business activities or
to any present or future products, prices, plans, forecasts, suppliers, clients, customers,
employees, consultants or investors; whether in oral, written, graphic or electronic form
(collectively referred to as “Information”).
	 
	 	   	Contractor acknowledges the confidential and secret character of the Information, and agrees
that the Information is the extremely valuable property of IntraBiotics or of the third
party from which IntraBiotics received such Information. Accordingly, Contractor agrees not
to reproduce any of the Information in any format, not to use the Information except in the
performance of the work described in this Agreement, and not to disclose all or any part of
the Information in any form to any third party, in each case either during the term of this
Agreement or for ten (10) years thereafter, except with the prior written consent of
IntraBiotics. Upon termination of this Agreement for any reason, including expiration of
the term of this Agreement, Contractor agrees to cease using and to return to IntraBiotics
all whole and partial copies and derivatives of the Information, whether in Contractor’s
possession or under Contractor’s direct or indirect control.

 

	 	   	Contractor shall not disclose or otherwise make available to IntraBiotics in any manner any
confidential information of Contractor or received by Contractor from third parties, unless
IntraBiotics first agrees in writing to receive such information.
	 
	 	4.  	Ownership of Work Product.
	 
	 	   	Contractor agrees that any and all ideas, developments, discoveries, improvements,
inventions and works of authorship (collectively, “Technology”) conceived, written, created
or first reduced to practice in the performance of work under this Agreement, together with
all intellectual property rights relating thereto (“Work Product”) shall be the sole and
exclusive property of IntraBiotics. Contractor hereby assigns to IntraBiotics all its
right, title and interest in and to any and all such Work Product, and shall not take any
action or permit any inaction that would encumber the Work Product or make it subject to any
liens, claims or demands of third parties, or otherwise adversely affect or interfere with
IntraBiotics’ ownership of the Work Product. Contractor hereby agrees not to use any
Technology or intellectual property rights that are owned or controlled by any third party
or are otherwise not available for use by Contractor or IntraBiotics in the course of
performing services pursuant to this Agreement unless Contractor first notifies IntraBiotics
of such intended use in advance and Contractor is free to use such Technology and
intellectual property to perform such services, and IntraBiotics agrees to permit such use.
	 
	 	   	Contractor further agrees that, except for Contractor’s rights in any Background Technology,
IntraBiotics possesses and shall retain all right, title and interest in all Contractor’s
Work Product under this Agreement. Contractor hereby grants to IntraBiotics a
non-exclusive, royalty-free and worldwide right to use and sublicense the use of any
Background Technology for the purpose of developing and marketing IntraBiotics products, but
not for the purpose of marketing any Background Technology separate from IntraBiotics
products.
	 
	 	   	Contractor further agrees to execute all papers, including without limitation all patent
applications, invention assignments and copyright assignments, and otherwise assist
IntraBiotics as reasonably required to perfect IntraBiotics’ right, title and interest in
Contractor’s Work Product as expressly granted to IntraBiotics under this Agreement. Such
assistance shall include but not be limited to providing affidavits or testimony in
connection with patent interference, validity or infringement proceedings and participating
in other legal proceedings. Reasonable costs related to such assistance, if required, shall
be paid by IntraBiotics. Contractor’s obligation to assist IntraBiotics as described above
in this paragraph shall continue beyond the termination of this Agreement. If IntraBiotics
is unable, after reasonable effort, to secure Contractor’s signature on any document as
provided in this Paragraph 4, Contractor hereby designates and appoints IntraBiotics and its
duly authorized officers and agents as its agent and attorney in fact to execute, verify and
file applications, and to do all other lawfully permitted acts necessary to achieve the
intent of this Paragraph 4 with the same legal force and effect as if executed by
Contractor.
	 
	 	5.  	Conflicting Engagements. Contractor will notify IntraBiotics in writing prior to
entering into any employment or consulting arrangement with one or more third parties which
involves subject matter substantially similar to services Contractor is to provide
hereunder or which is provided for the benefit of third parties who are competitors of
IntraBiotics. During the term of this Agreement, Contractor shall not accept any
employment or consulting work which conflicts with Contractor’s obligations to IntraBiotics
hereunder or which may involve use or disclosure of Information other than as permitted
hereunder.
	 
	 	6.  	Legal And Equitable Remedies. Contractor hereby acknowledges and agrees that in the
event of any breach of this Agreement by Contractor, including, without limitation, the
actual or threatened disclosure of Information without the prior express written consent of
IntraBiotics, IntraBiotics will suffer an irreparable injury, such that no remedy at law
will afford it adequate protection against, or appropriate compensation for, such injury.
Accordingly, Contractor hereby agrees that IntraBiotics shall be entitled to specific
performance of Contractor’s obligations under this Agreement, as well as such further
relief as may be granted by a court of competent jurisdiction.
	 
	 	7.  	Warranty; Indemnification. Contractor warrants that he or she has good and marketable
title to all of Contractor’s Work Product and that all material supplied and work performed
under this Agreement shall

 

	 	   	be in compliance with all applicable laws and regulations. Contractor further warrants that
the Work Product shall be free and clear of all liens, claims, encumbrances or demands of
third parties, including any claims by any such third parties with respect to such third
parties’ intellectual property rights in the Work Product. Contractor shall indemnify,
defend and hold harmless IntraBiotics and its officers, agents, directors, employees, and
customers from and against any claim, liability, loss, judgment or expense (including
reasonable attorneys’ and expert witnesses’ fees and costs) resulting from or arising out of
any such claims by any third parties which are based upon or are the result of any breach of
such warranty.
	 
	 	8.  	Term; Termination. Either IntraBiotics or Contractor may terminate this Agreement upon
thirty (30) days prior written notice to the other. In the event this Agreement is
terminated, Contractor shall promptly upon termination return all Information (including
all copies thereof) as provided in Section 3, deliver all Work Product and related
documentation to IntraBiotics, and provide IntraBiotics with an invoice for any work
provided by Contractor for which compensation has not already been paid. If compensation
has been advanced to Contractor, Contractor shall reimburse any amounts for which work has
not been performed prior to the date of the notice of termination. Sections 3, 4, 5, 6, 7,
9 and 11 shall survive the termination of this Agreement for any reason, including
expiration of the term of this Agreement.
	 
	 	9.  	Compliance with Applicable Laws. Contractor warrants that all material supplied and
work performed under this Agreement shall be in compliance with all applicable laws and
regulations.
	 
	 	10.  	Independent Contractor. Contractor is an independent contractor, is not an agent or
employee of IntraBiotics and is not authorized to act on behalf of IntraBiotics.
Contractor will not be eligible for any employee benefits, nor will IntraBiotics make
deductions from any amounts payable to Contractor for taxes. Payment of all taxes due on
any amounts paid to Contractor hereunder shall be the sole responsibility of Contractor.
	 
	 	11.  	General. The parties’ rights and obligations under this Agreement will bind and inure
to the benefit of their respective successors and assigns, except that Contractor may not
delegate or assign any of his or her obligations or rights under this Agreement without
IntraBiotics’ prior written consent. This Agreement and Exhibits A and B, attached hereto
and hereby incorporated herein, constitute the parties’ final, exclusive and complete
understanding and agreement with respect to the subject matter hereof, and supersede all
prior and contemporaneous understandings and agreements relating to its subject matter.
This Agreement may not be waived, modified or amended unless mutually agreed upon in
writing by both parties. In the event any provision of this Agreement is found to be
legally unenforceable, such provision shall be deemed deleted from the Agreement and such
unenforceability shall not prevent enforcement of any other provision of the Agreement.
This Agreement shall be governed by the laws of the State of California, excluding its
conflicts of laws principles. Any notices required or permitted hereunder shall be given
to the appropriate party at the address specified below or at such other address as the
party shall specify in writing. Such notice shall be deemed given either upon personal
delivery, one (1) day after being sent by overnight delivery service, three (3) days after
the date of mailing if sent by certified or registered mail, postage prepaid, or on the day
of transmission by facsimile, provided that the notifying party confirms receipt of such
transmission with the other party by telephone. This Agreement may be executed in one or
more counterparts, each of which shall be deemed an original and all of which together
shall constitute a single instrument.

          In Witness Whereof, the parties hereto have executed this Agreement as of the
Effective Date.

	 	 	 	 	 	 	 
	INTRABIOTICS	 	CONTRACTOR
	 
	 	 	 	 	 	 
	Signature:

	 	/s/ Henry J. Fuchs
	 	Signature:
	 	/s/ Gregory W. Schafer
	

	 	 
	 	 	 	 
	 
	 	 	 	 	 	 
	Date:

	 	 	 	Date:
	 	Feb 9, 2005
	

	 	 
	 	 	 	 

 

	 	 	 	 	 	 	 
	INTRABIOTICS	 	CONTRACTOR
	Name:

	 	Henry J. Fuchs, MD
	 	Name:
	 	Gregory W. Schafer
	 
	 	 	 	 	 	 
	Title:

	 	President & CEO	 	 	 	 
	 
	 	 	 	 	 	 
	Address:

	 	2483 E. Bayshore Road

Suite 100

Palo Alto, CA 94303
	 	Address:
	 	

	 
	 	 	 	 	 	 
	Telephone:

	 	650-526-6800
	 	Telephone:
	 	

 

EXHIBIT A

Description of services to be provided from _January 15, 2005 to December 31, 2005_:

	•  	Scope of Services: General financial and business development consulting services
	 
	•  	All invoices will be submitted to the attention of Henry Fuchs, MD, President & CEO, IntraBiotics Pharmaceuticals, 2483
E. Bayshore Road, Suite 100, Palo Alto, CA 94303
	 
	•  	Henry Fuchs, MD will be the primary IntraBiotics contact.

 

AMENDMENT TO CONSULTING AGREEMENT BETWEEN INTRABIOTICS PHARMACEUTICALS, INC. AND

GREGORY W. SCHAFER

     This Amendment to the Consulting Agreement Between IntraBiotics Pharmaceuticals, Inc. and
GREGORY W. SCHAFER (the “Amendment”) is made and entered into effective as of March 1, 2005
(the “Amendment Effective Date”), by and between IntraBiotics, Inc., a Delaware
corporation (“IntraBiotics”) having its principal place of business at 2483 E. Bayshore
Road, Suite 100, Palo Alto, CA 94303 and GREGORY W. SCHAFER  (the “Consultant”).

     Whereas, IntraBiotics and Consultant entered into a consulting agreement, made
effective between such parties as of January 15, 2005, (the “Agreement”) regarding general
financial and business development consulting services; and

     Whereas, IntraBiotics and Consultant desire to amend Section 2 of the Agreement as
set forth below.

     Now Therefore, in consideration of the premises and of the covenants contained herein
and in the Agreement, the Parties hereto mutually agree as follows:

	   	1. Amendment of the Agreement

     The Parties hereby agree to amend the terms of the Agreement as provided below, effective as
of the Amendment Effective Date. To the extent that the Agreement is explicitly amended by this
Amendment, the terms of the Amendment will control where the terms of the Agreement are contrary to
or conflict with the following provisions. Where the Agreement is not explicitly amended, the
terms of the Agreement will remain in force. Capitalized terms used in this Amendment that are not
otherwise defined herein shall have the same meanings as such terms are defined in the Agreement.

     1.1 Amendment of Section 2 of the Agreement. Section 2 of the Agreement is hereby deleted and
replaced in its entirety with the following:

“2. Payment for Services”. Effective March 1, 2005, IntraBiotics shall pay Consultant, on
account of services provided pursuant hereto, a fee of $180.00 per hour, prorated as
appropriate. Travel and out-of-pocket expenses will be billed separately at cost. Payment
shall be made on a monthly basis within fifteen (15) days upon presentation of invoice from
Consultant.

	   	2. Miscellaneous

     2.1 Full Force and Effect. This Amendment amends the terms of the Agreement and is deemed
incorporated into, and governed by all other terms of, the Agreement. The provisions of the
Agreement, as amended by this Amendment, remain in full force and effect.

     2.2 Counterparts. This Amendment may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same
instrument.

     In Witness Whereof, the Parties hereto have duly executed this Amendment by their
authorized officers as of the date and year first above written.

 

	 	 	 	 	 	 	 
	INTRABIOTICS	 	CONTRACTOR
	 
	 	 	 	 	 	 
	By:

	 	/s/ Henry J. Fuchs
	 	By:
	 	/s/ Gregory W. Schafer
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	Name:

	 	Henry J. Fuchs, MD
	 	Name:
	 	Gregory W. Schafer
	 
	 	 	 	 	 	 
	Date:

	 	March 1, 2005
	 	Date:
	 	March 1, 2005
	 
	 	 	 	 	 	 
	Title:

	 	President and CEO
	 	Title:
	 	Financial Consultant

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}]]